Portfolio planning and risk management in the pharmaceutical industry 1

Published on March 29, 2017   53 min

Other Talks in the Series: Topical Talks

0:00
I am Joachim Greuel, Managing Director at Bioscience Valuation, a company engaged in portfolio management and risk management as well. And I'm going to talk about Portfolio Planning and Risk Management in the Pharmaceutical Industry.
0:21
Before I begin, a few words about myself, I studied biology in Germany and in the UK, and received a PhD in neuroscience from the Max-Planck-Institute for Brain Research. I also hold an MBA from the Wharton School of the University of Pennsylvania in the US with a healthcare management and finance focus. I also served as academic director and professor at the IE Business School in Madrid, teaching courses related to pharmacoeconomics and also related to portfolio managements in the pharmaceutical industry. Before I co-founded Bioscience Valuation more than 18 years ago, I worked for Bayer Pharmaceuticals as head of a research group for couple of years and also as investment manager for a venture capital fund in Switzerland.
Hide

Portfolio planning and risk management in the pharmaceutical industry 1

Embed in course/own notes